CA Stock MarketDetailed Quotes

PHRX Pharmadrug Inc

Watchlist

0.010
0.0000.00%

15min DelayTrading Aug 16 11:02 ET

1.07MMarket Cap-43P/E (TTM)

Pharmadrug Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

26.14%149.55K

-1.09%218.22K

28.50%423.06K

-72.62%188.42K

-6.20%118.55K

-19.21%220.62K

-74.58%329.24K

-72.45%688.19K

-Cash and cash equivalents

1,286.75%137.61K

2,367.17%206.28K

4,705.63%411.12K

474.15%160.1K

-48.54%9.92K

-89.18%8.36K

-99.11%8.56K

-98.40%27.88K

-Accounts receivable

----

--0

Total current assets

-76.09%265.52K

-64.96%425.14K

-55.51%596.22K

-35.12%1.17M

-57.56%1.11M

97.98%1.21M

-15.92%1.34M

-34.97%1.8M

Non current assets

-Accumulated depreciation

----

70.67%-38.99K

-Long term equity investment

----

--0

-Goodwill

-94.64%577.85K

-94.52%590.41K

-94.40%602.97K

-0.31%10.77M

-0.35%10.77M

-37.66%10.77M

-39.57%10.77M

-38.42%10.81M

-Other intangible assets

61.81%3.61M

32.12%3.52M

24.09%3.43M

-19.30%2.23M

-62.35%2.23M

-55.23%2.66M

-52.26%2.76M

-55.01%2.76M

Regulatory assets

-93.82%60.98K

-93.31%65.82K

-98.08%19.15K

-3.30%977.69K

1,120.01%987.27K

622.97%983.41K

1,088.03%997.07K

1,428.66%1.01M

Total assets

364.23%60.98K

609.72%65.82K

-16.46%19.15K

-90.36%3.56K

-81.27%13.14K

-79.07%9.27K

-35.95%22.93K

53.00%36.87K

Liabilities

Current liabilities

Current debt and capital lease obligation

-15.01%1.34M

-2.50%1.36M

24.19%1.77M

14.58%1.6M

104,949.40%1.58M

5,612.46%1.39M

3,233.76%1.42M

11,148.67%1.4M

-Current debt

-15.01%1.34M

-2.50%1.36M

24.19%1.77M

14.58%1.6M

104,949.40%1.58M

--1.39M

--1.42M

--1.4M

-Current capital lease obligation

----

--0

-accounts payable

-41.16%352.88K

-21.51%440.42K

-14.41%449.57K

97.34%644.96K

49.81%599.77K

100.98%561.1K

110.96%525.29K

58.77%326.82K

-Total tax payable

--0

-14.96%1.08M

-47.77%1.08M

-48.34%1.08M

-50.34%1.08M

-13.55%1.27M

Current accrued expenses

-15.79%326.77K

33.94%396.77K

80.40%448.58K

78.14%370.71K

119.52%388.04K

9.79%296.22K

32.14%248.66K

15.90%208.1K

Current liabilities

-21.24%2.02M

-2.44%2.2M

21.32%2.66M

35.40%2.62M

163.57%2.56M

292.66%2.25M

357.77%2.2M

386.05%1.93M

Non current liabilities

-Long term debt

----

--0

Non current accrued expenses

----

--0

Total non current liabilities

-44.59%2.02M

-34.02%2.2M

-18.68%2.66M

15.44%3.7M

19.83%3.64M

25.21%3.33M

23.42%3.28M

71.59%3.2M

Shareholders'equity

Share capital

8.94%34.01M

8.74%33.95M

6.39%33.21M

0.00%31.22M

0.22%31.22M

1.43%31.22M

1.99%31.22M

-common stock

8.94%34.01M

8.74%33.95M

6.39%33.21M

0.00%31.22M

0.22%31.22M

1.43%31.22M

1.99%31.22M

Retained earnings

--0

--136.1K

--149.01K

----

--0

----

Gains losses not affecting retained earnings

2.13%-45.6K

3.38%-45.6K

-82.36%-45.6K

7.57%-45.6K

-141.42%-46.6K

-205.23%-47.2K

79.43%-25.01K

80.82%-49.34K

Total equity

-92.90%843.37K

-91.53%1.02M

-90.10%1.2M

-5.28%11.94M

-11.50%11.88M

-33.29%11.99M

-37.95%12.11M

-38.16%12.6M

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	26.14%149.55K	-1.09%218.22K	28.50%423.06K	28.50%423.06K	-72.62%188.42K	-6.20%118.55K	-19.21%220.62K	-74.58%329.24K	-74.58%329.24K	-72.45%688.19K
-Cash and cash equivalents	1,286.75%137.61K	2,367.17%206.28K	4,705.63%411.12K	4,705.63%411.12K	474.15%160.1K	-48.54%9.92K	-89.18%8.36K	-99.11%8.56K	-99.11%8.56K	-98.40%27.88K
-Accounts receivable	----	----	----	----	----	----	----	----	----	--0
Total current assets	-76.09%265.52K	-64.96%425.14K	-55.51%596.22K	-55.51%596.22K	-35.12%1.17M	-57.56%1.11M	97.98%1.21M	-15.92%1.34M	-15.92%1.34M	-34.97%1.8M
Non current assets
-Accumulated depreciation	----	----	----	----	----	----	----	----	----	70.67%-38.99K
-Long term equity investment	----	----	----	----	----	----	----	----	----	--0
-Goodwill	-94.64%577.85K	-94.52%590.41K	-94.40%602.97K	-94.40%602.97K	-0.31%10.77M	-0.35%10.77M	-37.66%10.77M	-39.57%10.77M	-39.57%10.77M	-38.42%10.81M
-Other intangible assets	61.81%3.61M	32.12%3.52M	24.09%3.43M	24.09%3.43M	-19.30%2.23M	-62.35%2.23M	-55.23%2.66M	-52.26%2.76M	-52.26%2.76M	-55.01%2.76M
Regulatory assets	-93.82%60.98K	-93.31%65.82K	-98.08%19.15K	-98.08%19.15K	-3.30%977.69K	1,120.01%987.27K	622.97%983.41K	1,088.03%997.07K	1,088.03%997.07K	1,428.66%1.01M
Total assets	364.23%60.98K	609.72%65.82K	-16.46%19.15K	-16.46%19.15K	-90.36%3.56K	-81.27%13.14K	-79.07%9.27K	-35.95%22.93K	-35.95%22.93K	53.00%36.87K
Liabilities
Current liabilities
Current debt and capital lease obligation	-15.01%1.34M	-2.50%1.36M	24.19%1.77M	24.19%1.77M	14.58%1.6M	104,949.40%1.58M	5,612.46%1.39M	3,233.76%1.42M	3,233.76%1.42M	11,148.67%1.4M
-Current debt	-15.01%1.34M	-2.50%1.36M	24.19%1.77M	24.19%1.77M	14.58%1.6M	104,949.40%1.58M	--1.39M	--1.42M	--1.42M	--1.4M
-Current capital lease obligation	----	----	----	----	----	----	----	----	----	--0
-accounts payable	-41.16%352.88K	-21.51%440.42K	-14.41%449.57K	-14.41%449.57K	97.34%644.96K	49.81%599.77K	100.98%561.1K	110.96%525.29K	110.96%525.29K	58.77%326.82K
-Total tax payable	--0	--0	--0	--0	-14.96%1.08M	-47.77%1.08M	-48.34%1.08M	-50.34%1.08M	-50.34%1.08M	-13.55%1.27M
Current accrued expenses	-15.79%326.77K	33.94%396.77K	80.40%448.58K	80.40%448.58K	78.14%370.71K	119.52%388.04K	9.79%296.22K	32.14%248.66K	32.14%248.66K	15.90%208.1K
Current liabilities	-21.24%2.02M	-2.44%2.2M	21.32%2.66M	21.32%2.66M	35.40%2.62M	163.57%2.56M	292.66%2.25M	357.77%2.2M	357.77%2.2M	386.05%1.93M
Non current liabilities
-Long term debt	----	----	----	----	----	----	----	----	----	--0
Non current accrued expenses	----	----	----	----	----	----	----	--0	--0	--0
Total non current liabilities	-44.59%2.02M	-34.02%2.2M	-18.68%2.66M	-18.68%2.66M	15.44%3.7M	19.83%3.64M	25.21%3.33M	23.42%3.28M	23.42%3.28M	71.59%3.2M
Shareholders'equity
Share capital	8.94%34.01M	8.74%33.95M	6.39%33.21M	6.39%33.21M	0.00%31.22M	0.22%31.22M	1.43%31.22M	1.99%31.22M	1.99%31.22M	1.99%31.22M
-common stock	8.94%34.01M	8.74%33.95M	6.39%33.21M	6.39%33.21M	0.00%31.22M	0.22%31.22M	1.43%31.22M	1.99%31.22M	1.99%31.22M	1.99%31.22M
Retained earnings	--0	--136.1K	--149.01K	--149.01K	----	----	----	--0	--0	----
Gains losses not affecting retained earnings	2.13%-45.6K	3.38%-45.6K	-82.36%-45.6K	-82.36%-45.6K	7.57%-45.6K	-141.42%-46.6K	-205.23%-47.2K	79.43%-25.01K	79.43%-25.01K	80.82%-49.34K
Total equity	-92.90%843.37K	-91.53%1.02M	-90.10%1.2M	-90.10%1.2M	-5.28%11.94M	-11.50%11.88M	-33.29%11.99M	-37.95%12.11M	-37.95%12.11M	-38.16%12.6M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

PHRX Pharmadrug Inc

Pharmadrug Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow